AI RESEARCH ANALYSIS
Cardiovascular measures from abdominal MRI provide insights into abdominal vessel genetic architecture
This study explores whether whole-body MRI scans can provide useful insights into heart and blood vessel health, currently not a typical use for heart analysis. We found links between heart size, blood vessel health, and disease risk by analyzing data from over 44,000 people. We confirmed our results with other types of heart scans and identified inherited (genetic) factors influencing heart and vessel size. Larger aortas were linked to aneurysms, and heart volume was connected to heart disease. We developed a genetic risk score to help predict certain conditions. Our study demonstrates how artificial intelligence (AI) and MRI scans can enhance heart disease research and potentially be used for identification and prevention.
Executive Impact
This research leverages deep learning to analyze abdominal MRI scans from over 44,000 UK Biobank participants, generating six image-derived phenotypes (IDPs) related to heart volume and vessel cross-sectional areas. The study establishes strong correlations with existing cardiac MRI measures, identifies significant associations between these IDPs and cardiovascular disease outcomes (e.g., infrarenal descending aorta CSA with abdominal aortic aneurysm, heart volume with dysrhythmia and valve defects), and uncovers 72 genetic associations at 59 loci, 15 of which are novel. A polygenic risk score (PRS) for vessel CSA is developed, showing predictive value for thoracic aneurysm diagnosis. Heritability enrichment analysis highlights vascular tissue's role in these traits. This work demonstrates the potential of non-specific abdominal MRI in cardiovascular disease risk assessment and identifies novel genetic insights into vascular dimensions.
0
Participants Analyzed
0
Novel Genetic Loci Identified
0
Genomic Associations
Deep Analysis & Enterprise Applications
Select a topic to dive deeper, then explore the specific findings from the research, rebuilt as interactive, enterprise-focused modules.
0
Correlation between abdominal and cardiac MRI IDPs in overlapping regions
AI-Powered IDP Generation Workflow
UK Biobank Abdominal MRI Scans (44,541 participants)
→
Deep Learning Segmentation (Heart, Aorta, Vena Cava)
→
Extraction of 6 Image-Derived Phenotypes (IDPs)
→
Genetic & Environmental Factor Analysis
→
Disease Outcome Association Studies (Phenome-Wide & Survival)
→
Genetic Architecture Insights & PRS Development
| Feature | Abdominal MRI (This Study) | Cardiac MRI (CMR) |
|---|---|---|
| Coverage |
|
|
| Vessel CSA Quantification |
|
|
| Genetic Factor Discovery |
|
|
| Disease Risk Assessment |
|
|
Uncovering Novel Genetic Determinants of Vascular Health
This study significantly advances our understanding of the genetic basis of cardiovascular health by identifying novel loci associated with abdominal vessel dimensions.
Challenge: Previous studies focused primarily on the thoracic aorta due to the limitations of cardiac MRI's field of view, leaving the genetic architecture of abdominal vessels underexplored despite their clinical importance for conditions like Abdominal Aortic Aneurysm (AAA).
Solution: By utilizing deep learning to extract detailed Image-Derived Phenotypes (IDPs) from neck-to-knee abdominal MRI scans, we overcame the FoV limitation. This enabled the quantification of infrarenal and suprarenal aortic cross-sectional areas (CSAs) and the vena cava, alongside heart volume.
Outcome: A genome-wide association study (GWAS) on these novel IDPs identified 72 associations at 59 loci, with 15 being entirely novel. Critically, we established a strong genetic correlation between suprarenal aorta CSA and aortic aneurysm (rg = 0.87), and identified a region-specific association at the MRC2 locus for infrarenal aorta CSA, which colocalizes with MRC2 expression in aortic and tibial arteries. This highlights MRC2's role in collagen degradation and its implications for AAA risk. The developed polygenic risk scores also showed predictive value for aneurysm diagnoses.
Calculate Your Potential ROI with AI
Estimate the efficiency gains and cost savings your enterprise could achieve by implementing AI-powered solutions, based on industry benchmarks and operational data.
Estimated Annual Savings
$0
Annual Hours Reclaimed
0
Your AI Implementation Roadmap
A strategic overview of the typical phases involved in integrating AI into your enterprise, designed for clarity and actionable steps.
Phase 1: Data Integration & Model Adaptation
Integrate existing abdominal MRI datasets and adapt pre-trained deep learning models for your specific imaging protocols. Establish data pipelines for efficient IDP extraction.
Phase 2: Validation & Custom Phenotype Development
Validate IDP accuracy against ground truth in a representative subset of your data. Develop custom image-derived phenotypes relevant to your specific research or clinical focus.
Phase 3: Association & Predictive Modeling
Perform association studies linking new IDPs with clinical outcomes and genetic data. Develop and validate polygenic risk scores or other predictive models for early risk stratification.
Phase 4: Clinical Translation & Large-Scale Deployment
Integrate validated IDP extraction and predictive models into clinical workflows. Implement solutions for large-scale population screening or research cohorts, ensuring regulatory compliance.
Ready to Transform Your Enterprise with AI?
Schedule a personalized consultation with our AI experts to discuss how these insights can be tailored to your organization's unique needs and objectives.
Ready to Get Started?
Book Your Free Consultation.
Let's Discuss Your AI Strategy!
Lets Discuss Your Needs
Select a Date
Sun
Mon
Tue
Wed
Thu
Fri
Sat